EUVIMEDEUVIMED entdecken
Crossref

Artificial Intelligence‐Based Diets: A Role in the Nutritional Treatment of Metabolic Dysfunction‐Associated Steatotic Liver Disease?

Tugce Ozlu Karahan, Emre Batuhan Kenger, Yusuf Yilmaz

Journal of Human Nutrition and Dietetics · 2025-04 · 38 (2)

DOI: 10.1111/jhn.70033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Human Nutrition and Dietetics, online erschienen am 27.02.2025. Verfasst von Tugce Ozlu Karahan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Dietetics, Faculty of Health Sciences, Istanbul Bilgi University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Artificial Intelligence, Diet, Fatty Liver. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a growing global health concern. Effective management of this condition relies heavily on lifestyle modifications and dietary interventions. In this study, we sought to evaluate the dietary plans for MASLD generated by ChatGPT (GPT‐4o) according to current guideline recommendations.

Methods

ChatGPT was used to create single‐day meal plans for 48 simulated patients with MASLD, tailored to individual characteristics such as age, gender, height, weight and transient elastography parameters. The plans were assessed for appropriateness according to disease‐specific guidelines.

Results

The mean energy content of the menus planned by ChatGPT was 1596.9 ± 141.5 kcal with a mean accuracy of 91.3 ± 11.0%, and fibre content was 22.0 ± 0.6 g with a mean accuracy of 88.1 ± 2.5%. However, they exhibited elevated levels of protein, fat and saturated fat acids. Conversely, the carbohydrate content was lower. ChatGPT recommended weight loss for obese patients but did not extend this advice to normal‐weight and overweight individuals. Notably, recommendations for a Mediterranean diet and physical activity were absent.

Conclusions

ChatGPT shows potential in developing dietary plans for MASLD management. However, discrepancies in macronutrient distributions and the omission of key evidence‐based recommendations highlight the need for further refinement. To enhance the effectiveness of AI tools in dietary recommendations, alignment with established guidelines must be improved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceDietFatty LiverHumansMaleFemaleMiddle AgedAdultAgedEnergy Intake

Stichwörter der Autor:innen

ChatGPTartificial intelligenceguideline recommendationsmetabolic dysfunction‐associated steatotic liver diseasenutritional therapy

Autor:innen und Institutionen

  • Department of Nutrition and Dietetics, Faculty of Health Sciences, Istanbul Bilgi University, Istanbul, Turkey.
  • Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Ozlu Karahan, T., Kenger, E. B., & Yilmaz, Y. (2025). Artificial Intelligence‐Based Diets: A Role in the Nutritional Treatment of Metabolic Dysfunction‐Associated Steatotic Liver Disease?. Journal of Human Nutrition and Dietetics, 38(2). https://doi.org/10.1111/jhn.70033

Vancouver

Ozlu Karahan T, Kenger EB, Yilmaz Y. Artificial Intelligence‐Based Diets: A Role in the Nutritional Treatment of Metabolic Dysfunction‐Associated Steatotic Liver Disease?. Journal of Human Nutrition and Dietetics. 2025;38(2). doi:10.1111/jhn.70033

BibTeX
@article{OzluKarahan2025,
  author = {Ozlu Karahan, Tugce and Kenger, Emre Batuhan and Yilmaz, Yusuf},
  title = {Artificial Intelligence‐Based Diets: A Role in the Nutritional Treatment of Metabolic Dysfunction‐Associated Steatotic Liver Disease?},
  journal = {Journal of Human Nutrition and Dietetics},
  year = {2025},
  volume = {38},
  number = {2},
  doi = {10.1111/jhn.70033}
}
Kostenlos starten →